This topic contains a solution. Click here to go to the answer

Author Question: Isoflurane (Forane) was administered as anesthesia for a client who had abdominal surgery. During ... (Read 31 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
Isoflurane (Forane) was administered as anesthesia for a client who had abdominal surgery. During postanesthesia recovery, the client begins to shiver. What should the nurse do?
 
  Standard Text: Select all that apply.
  1. Check the client's temperature.
  2. Notify the anesthesiologist immediately.
  3. Put warm blankets on the client.
  4. Assure the client that shivering is common.
  5. Administer prn pain medication.

Question 2

During review of postoperative medical orders, the nurse notes an order for ondansetron (Zofran) prn. When would the nurse expect to administer this medication?
 
  Standard Text: Select all that apply.
  1. If the client has temperature elevation
  2. If the client complains of nausea
  3. Approximately 30 minutes before the end of the procedure
  4. If the client reports breakthrough pain between regular pain medication administration
  5. Just before the first dressing change



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nital

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Correct Answer: 3,4
Rationale 1: It is unlikely that the client's temperature is causing this shivering.
Rationale 2: There is no reason to notify the anesthesiologist with this information.
Rationale 3: Warm blankets may be applied for client comfort.
Rationale 4: Shivering is common after receiving isofurane.
Rationale 5: This shivering does not generally correlate with pain.
Global Rationale: Shivering is common after receiving isofurane and warm blankets may be applied for client comfort. It is unlikely that the client's temperature is causing this shivering. There is no reason to notify the anesthesiologist with this information. This shivering does not generally correlate with pain.

Answer to Question 2

Correct Answer: 2,3
Rationale 1: This medication is not used for temperature elevation.
Rationale 2: Ondansetron (Zofran) is used as an antiemetic.
Rationale 3: If administered approximately 30 minutes before the end of the procedure, acute nausea and vomiting may be avoided.
Rationale 4: Ondansetron (Zofran) is not used for pain control.
Rationale 5: There is no indication for the administration of ondansetron (Zofran) associated with dressing changes.
Global Rationale: Ondansetron (Zofran) is used as an antiemetic. If administered approximately 30 minutes before the end of the procedure, acute nausea and vomiting may be avoided. This medication is not used for temperature elevation or pain control. There is no indication for the administration of ondansetron (Zofran) associated with dressing changes.




leilurhhh

  • Member
  • Posts: 560
Reply 2 on: Jul 23, 2018
:D TYSM


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Excellent

 

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library